MSCIS suitable for phacolytic glaucoma patients

Article

Manual small incision cataract surgery (MSCIS) with trypan blue staining of the anterior capsule is a safe and effective method of cataract extraction for patients with phacolytic glaucoma.

Manual small incision cataract surgery (MSCIS) with trypan blue staining of the anterior capsule is a safe and effective method of cataract extraction for patients with phacolytic glaucoma, according to a report published in the March issue of the British Journal of Ophthalmology.

Rengaraj Venkatesh and colleagues from the Aravind Eye Hospital, India and the Eye Institute at Tan Tock Seng Hospital, Singapore, conducted a non-randomized interventional case series of three patients with phacolytic glaucoma undergoing cataract extraction by MSICS, with trypan blue staining of the anterior capsule.

The mean preoperative intraocular pressure (IOP) was 46.2 mmHg. In 31 patients, an intraocular lens (IOL) was implanted in the posterior chamber and in the further two subjects, the posterior capsule was removed leaving aphakia due to severe pre-existing zonulysis. Postoperative best corrected visual acuity (BCVA) was 20/60 or better in 29 patients and 20/40 or better in 26 patients. In all 33 cases, the IOP was 22 mmHg or less without the use of anti-glaucoma medications (mean IOP was 15.1 mmHg). Postoperative corneal oedema occurred in 11 cases and anterior chamber inflammation was noted in nine cases. Both were resolved with standard medical therapy.

The authors of the study concluded that MSCIS with trypan blue staining is a safe and effective method of extracting cataracts in patients with phacolytic glaucoma.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
© 2025 MJH Life Sciences

All rights reserved.